Aida Pharmaceuticals, Inc. (AIDA)

Aida Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Sep 30, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003
Revenue	40.51	29.2	29.64	24.53	15.65	12.59
Revenue Growth (YoY)	41.27%	-1.48%	20.86%	56.77%	24.27%	-
Cost of Revenue	18.2	14.56	14.3	8.39	4.82	4.77
Gross Profit	22.3	14.64	15.34	16.14	10.82	7.82
Selling, General & Admin	13.25	8.91	11.08	13.98	7.7	5.77
Research & Development	0.99	0.28	0.32	0.04	0.26	0.13
Operating Expenses	15.28	9.2	11.4	14.02	7.97	5.9
Operating Income	7.02	5.45	3.94	2.12	2.86	1.92
Interest Expense	-2.74	-2.02	-1.7	-1.1	-0.48	-0.34
Interest & Investment Income	-	-	-	-	-	0.12
Other Non Operating Income (Expenses)	1.28	1.04	0.09	0.44	0.16	0.27
EBT Excluding Unusual Items	5.56	4.46	2.32	1.46	2.53	1.97
Gain (Loss) on Sale of Investments	-0.01	0.11	-	-	-	-
Other Unusual Items	0.11	0.11	-	0.05	-	0.21
Pretax Income	-1.39	4.68	2.32	1.51	2.53	2.17
Income Tax Expense	-1.08	0.36	0.17	0.14	0.15	0.71
Earnings From Continuing Operations	-0.31	4.32	2.15	1.36	2.38	1.47
Earnings From Discontinued Operations	-	-	-	0.19	0.09	-
Net Income to Company	-0.31	4.32	2.15	1.55	2.47	1.47
Minority Interest in Earnings	-1.87	-1.58	-0.7	-0.08	-0.84	-0.13
Net Income	-2.18	2.74	1.45	1.47	1.63	1.33
Net Income to Common	-2.18	2.74	1.45	1.47	1.63	1.33
Net Income Growth	-	88.49%	-1.00%	-10.19%	22.51%	-
Shares Outstanding (Basic)	27	27	26	23	23	-
Shares Outstanding (Diluted)	27	27	26	23	23	-
Shares Change (YoY)	-1.65%	4.03%	10.53%	0.46%	-	-
EPS (Basic)	-0.08	0.10	0.06	0.06	0.07	-
EPS (Diluted)	-0.08	0.10	0.06	0.06	0.07	-
EPS Growth	-	81.18%	-10.43%	-10.60%	-	-
Free Cash Flow	2.58	4.37	0.9	5.13	-3.69	-0.58
Free Cash Flow Per Share	0.10	0.16	0.04	0.22	-0.16	-
Gross Margin	55.06%	50.13%	51.75%	65.80%	69.17%	62.09%
Operating Margin	17.34%	18.65%	13.28%	8.64%	18.25%	15.25%
Profit Margin	-5.38%	9.38%	4.90%	5.99%	10.45%	10.60%
Free Cash Flow Margin	6.36%	14.95%	3.03%	20.92%	-23.56%	-4.58%
EBITDA	9.51	7.4	6.03	3.81	3.47	2.41
EBITDA Margin	23.49%	25.34%	20.33%	15.54%	22.15%	19.18%
D&A For EBITDA	2.49	1.96	2.09	1.69	0.61	0.49
EBIT	7.02	5.45	3.94	2.12	2.86	1.92
EBIT Margin	17.34%	18.65%	13.28%	8.64%	18.25%	15.25%
Effective Tax Rate	-	7.69%	7.46%	9.59%	5.96%	32.48%
Advertising Expenses	-	0.49	0.58	0.13	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.